These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 2667106)

  • 1. Overview of Scandinavian in vitro studies with ciprofloxacin.
    Forsgren A
    Scand J Infect Dis Suppl; 1989; 60():16-22. PubMed ID: 2667106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-antibiotic suppressive effect of ciprofloxacin against gram-positive and gram-negative bacteria.
    Chin NX; Neu HC
    Am J Med; 1987 Apr; 82(4A):58-62. PubMed ID: 3578330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of ciprofloxacin against gram-positive bacteria. An overview.
    Kayser FH; Novak J
    Am J Med; 1987 Apr; 82(4A):33-9. PubMed ID: 3555058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
    Cetinkaya E; Coban AY; Durupinar B
    Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of pefloxacin against gram-negative and gram-positive bacteria in comparison with other antibiotics.
    Debbia E; Schito GC; Nicoletti G; Speciale A
    Chemioterapia; 1987 Oct; 6(5):319-23. PubMed ID: 3480779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative in vitro activity of ciprofloxacin against aerobic and anaerobic bacteria from clinical isolates.
    Klietmann W; Focht J; Nösner K
    Arzneimittelforschung; 1987 Jun; 37(6):661-6. PubMed ID: 2822054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of ciprofloxacin's synergism with other agents by multiple in vitro methods.
    Moody JA; Gerding DN; Peterson LR
    Am J Med; 1987 Apr; 82(4A):44-54. PubMed ID: 3107380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentration-dependent bacterial killing, adaptive resistance and post-antibiotic effect of ciprofloxacin alone and in combination with gentamicin.
    Gould IM; Milne K; Jason C
    Drugs Exp Clin Res; 1990; 16(12):621-8. PubMed ID: 2130004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial activity of the metabolites of ciprofloxacin and its significance in the bioassay.
    Zeiler HJ; Petersen U; Gau W; Ploschke HJ
    Arzneimittelforschung; 1987 Feb; 37(2):131-4. PubMed ID: 3555512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro activity of ciprofloxacin and other unrelated antimicrobials against bacterial respiratory tract pathogens.
    Felmingham D; Robbins MJ; Baskerville AJ; Sanghrajka MD; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1989; 15(2):59-62. PubMed ID: 2737080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial activity of ciprofloxacin administered intravenously in a pharmacodynamic in vitro model.
    Esposito S; Jansen A
    Int J Clin Pharmacol Res; 1991; 11(4):193-9. PubMed ID: 1813438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro activity of ciprofloxacin, ofloxacin and pefloxacin against resistant clinical isolates.
    Periti P; Mazzei T; Nicoletti P
    Chemioterapia; 1987 Apr; 6(2):75-8. PubMed ID: 3474081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of ciprofloxacin against gram-positive cocci.
    Barry AL; Jones RN
    Am J Med; 1987 Apr; 82(4A):27-32. PubMed ID: 3578323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of in vitro activity of ciprofloxacin and pefloxacin against strains isolated from clinical material].
    Kumelj M; Rus A; Music E
    Plucne Bolesti; 1989; 41(3-4):193-5. PubMed ID: 2636406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aerobic bacteria isolated from blood cultures of patients and their antibiotic susceptibilities in Harare, Zimbabwe.
    Obi CL; Mazarura E
    Cent Afr J Med; 1996 Dec; 42(12):332-6. PubMed ID: 9164012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-antibiotic effect of three quinolones against gram negative isolates from urine.
    Alados JC; Gutierrez J; Garcia F; Liebana J; Piedrola G
    Med Lab Sci; 1990 Oct; 47(4):272-7. PubMed ID: 2283929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the cell wall on ciprofloxacin susceptibility in selected wild-type Gram-negative and Gram-positive bacteria.
    Berlanga M; Montero MT; Hernández-Borrell J; Viñas M
    Int J Antimicrob Agents; 2004 Jun; 23(6):627-30. PubMed ID: 15194135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-antibacterial effect of thymol.
    Zarrini G; Delgosha ZB; Moghaddam KM; Shahverdi AR
    Pharm Biol; 2010 Jun; 48(6):633-6. PubMed ID: 20645735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro activity of ciprofloxacin and sixteen other antimicrobial agents against blood culture isolates.
    Eltahawy AT
    J Chemother; 1993 Apr; 5(2):94-102. PubMed ID: 8515299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial activity of subinhibitory concentrations of ciprofloxacin against Pseudomonas aeruginosa as determined by the killing curve method and the postantibiotic effect.
    Zhanel GG; Crampton J; Kim S; Nicolle LE; Davidson RJ; Hoban DJ
    Chemotherapy; 1992; 38(6):388-94. PubMed ID: 1288962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.